Intraspinal neural stem cell transplantation in amyotrophic lateral sclerosis: Phase 1 trial outcomes

Annals of Neurology

Volumn 75, Issue 3, 2014, Pages 363-373

  Feldman, Eva L ^a   Boulis, Nicholas M ^b   Hur, Junguk ^a   Johe, Karl ^c   Rutkove, Seward B ^d   Federici, Thais ^b   Polak, Meraida ^b   Bordeau, Jane ^b   Sakowski, Stacey A ^e   Glass, Jonathan D ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Neuralstem Inc   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^e UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; AMYOTROPHIC LATERAL SCLEROSIS RATING SCALE REVISED SCORE; ARTICLE; BIOLOGICAL ACTIVITY; CERVICAL SPINAL CORD; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL ASSESSMENT TOOL; DISEASE COURSE; FEASIBILITY STUDY; FEMALE; FUNCTIONAL STATUS; HUMAN; MALE; NEURAL STEM CELL; NEURAL STEM CELL TRANSPLANTATION; PATIENT MONITORING; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; CERVICAL VERTEBRAE; FEMALE; HUMANS; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; NEURAL STEM CELLS; RECOVERY OF FUNCTION; SPINAL CORD; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

EID: 84897997188     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.24113     Document Type: Article

References (20)

1. Lunn JS, Sakowski SA, Hur J, Feldman EL,. Stem cell technology for neurodegenerative diseases. Ann Neurol 2011; 70: 353-361.
2. Hefferan MP, Galik J, Kakinohana O, et al. Human neural stem cell replacement therapy for amyotrophic lateral sclerosis by spinal transplantation. PLoS One 2012; 7: e42614.
3. Xu L, Ryugo DK, Pongstaporn T, et al. Human neural stem cell grafts in the spinal cord of SOD1 transgenic rats: differentiation and structural integration into the segmental motor circuitry. J Comp Neurol 2009; 514: 297-309.
4. Xu L, Shen P, Hazel T, et al. Dual transplantation of human neural stem cells into cervical and lumbar cord ameliorates motor neuron disease in SOD1 transgenic rats. Neurosci Lett 2011; 494: 222-226.
5. Xu L, Yan J, Chen D, et al. Human neural stem cell grafts ameliorate motor neuron disease in SOD-1 transgenic rats. Transplantation 2006; 82: 865-875.
6. Yan J, Xu L, Welsh AM, et al. Extensive neuronal differentiation of human neural stem cell grafts in adult rat spinal cord. PLoS Med 2007; 4: e39.
7. Boulis NM, Federici T, Glass JD, et al. Translational stem cell therapy for amyotrophic lateral sclerosis. Nat Rev Neurol 2011; 8: 172-176.
8. Lunn JS, Hefferan MP, Marsala M, Feldman EL,. Stem cells: comprehensive treatments for amyotrophic lateral sclerosis in conjunction with growth factor delivery. Growth Factors 2009; 27: 133-140.
9. Lunn JS, Sakowski SA, Federici T, et al. Stem cell technology for the study and treatment of motor neuron diseases. Regen Med 2011; 6: 201-213.
10. Silani V, Calzarossa C, Cova L, Ticozzi N,. Stem cells in amyotrophic lateral sclerosis: motor neuron protection or replacement? CNS Neurol Disord Drug Targets 2010; 9: 314-324.
11. Riley J, Butler J, Park J, et al. Targeted spinal cord therapeutics delivery: stabilized platform and microelectrode recording guidance validation. Stereotact Funct Neurosurg 2007; 86: 67-74.
12. Riley JP, Raore B, Taub JS, et al. Platform and cannula design improvements for spinal cord therapeutics delivery. Neurosurgery 2011; 69 (2 suppl): ons147-ons154; discussion ons155.
13. Raore B, Federici T, Taub J, et al. Cervical multilevel intraspinal stem cell therapy: assessment of surgical risks in Gottingen minipigs. Spine (Phila Pa 1976) 2011; 36: E164-E171.
14. Riley J, Federici T, Park J, et al. Cervical spinal cord therapeutics delivery: preclinical safety validation of a stabilized microinjection platform. Neurosurgery 2009; 65: 754-761; discussion 761-762.
15. Glass JD, Boulis NM, Johe K, et al. Lumbar intraspinal injection of neural stem cells in patients with amyotrophic lateral sclerosis: results of a phase I trial in 12 patients. Stem Cells 2012; 30: 1144-1151.
16. Riley J, Federici T, Polak M, et al. Intraspinal stem cell transplantation in amyotrophic lateral sclerosis: a phase I safety trial, technical note, and lumbar safety outcomes. Neurosurgery 2012; 71: 405-416.
17. Riley J, Glass J, Feldman EL, et al. Intraspinal stem cell transplantation in amyotrophic lateral sclerosis: a phase I trial, cervical microinjection, and final surgical safety outcomes. Neurosurgery 2014; 74: 77-87.
18. Guo X, Johe K, Molnar P, et al. Characterization of a human fetal spinal cord stem cell line, NSI-566RSC, and its induction to functional motoneurons. J Tissue Eng Regen Med 2010; 4: 181-193.
19. Johe KK, Hazel TG, Muller T, et al. Single factors direct the differentiation of stem cells from the fetal and adult central nervous system. Genes Dev 1996; 10: 3129-3140.
20. Healy BC, Schoenfeld D,. Comparison of analysis approaches for phase III clinical trials in amyotrophic lateral sclerosis. Muscle Nerve 2012; 46: 506-511.